Cargando…
Chemotherapy in the Covid-19 era: the patient’s perception
BACKGROUND: The Covid-19 pandemic poses significant challenges for the management of patients with cancer. In our institution, we adapted our delivery of outpatient systemic anti-cancer therapy (SACT) by introducing a number of ‘risk-reducing’ measures including pre-assessment screening. AIMS: We so...
Autores principales: | Hennessy, Maeve A., Linehan, Anna, Cowzer, Darren, Coyne, Zachary L., Fitzpatrick, Orla, Barrett, Fiona, Ni Dhonaill, Roisin, Hennessy, Bryan T., Grogan, Liam, Morris, Patrick G., Breathnach, Oscar S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809239/ https://www.ncbi.nlm.nih.gov/pubmed/33449325 http://dx.doi.org/10.1007/s11845-020-02457-3 |
Ejemplares similares
-
COVID-19-related mortality in cancer patients in an Irish setting
por: Linehan, Anna, et al.
Publicado: (2021) -
1571P Chemotherapy in the COVID-19 era: The patient’s perception
por: Hennessy, M., et al.
Publicado: (2020) -
Delivery of systemic anti-cancer therapy during the COVID-19 pandemic
por: Fitzpatrick, Orla, et al.
Publicado: (2021) -
1762P Delivery of systemic anti-cancer therapy during the COVID-19 pandemic
por: Fitzpatrick, O., et al.
Publicado: (2020) -
One year of procarbazine lomustine and vincristine is poorly tolerated in low grade glioma: a real world experience in a national neuro-oncology centre
por: Keogh, Rachel J., et al.
Publicado: (2021)